Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry.Howard R. Terebelo, Robert M. Rifkin, Arlene S. Swern et al.|Journal of Clinical Oncology|2013Cited by 3
Connect MM: The multiple myeloma (MM) disease registry—Incidence of second primary malignancies (SPM).Robert M. Rifkin, Brian G.M. Durie, Rafat Abonour et al.|Journal of Clinical Oncology|2012Cited by 2
Changes in patient-reported outcomes in patients diagnosed with and treated for multiple myeloma in the Connect MM registry.Chris L. Pashos, Robert M. Rifkin, Jatin J. Shah et al.|Journal of Clinical Oncology|2013Cited by 1
Race- and health-related quality of life among patients newly diagnosed with multiple myeloma.Chris L. Pashos, Zeba M. Khan, Brian G.M. Durie et al.|Journal of Clinical Oncology|2012Cited by 1
Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM RegistryRafat Abonour, Robert M. Rifkin, Jatin J. Shah et al.|Blood|2013Cited by 0